Talk about 5G is everywhere right now, from the trade war with China to the ban on Huawei. Here's what 5G is and why it matters.Technologyread more
A federal judge in New York City on Wednesday said Deutsche Bank and Capital One can turn over financial documents related to President Donald Trump and his businesses in...Politicsread more
Shares of L Brands, the owner of Victoria's Secret and Bath & Body Works, rose nearly 11% in aftermarket trading Wednesday after the company reported it beat revenue and...Retailread more
CNEX, backed by Microsoft and Dell, filed new allegations in a Texas suit accusing China's Huawei and an executive of trade secrets theft.Technologyread more
Officials remained firmly committed to a "patient" policy stance at their meeting earlier this month.The Fedread more
A slew of retail earnings the past two weeks makes it clear that while Americans continue to shop, they aren't ringing registers at department stores.Retailread more
Stocks that would benefit from a federal infrastructure spending program fell after President Trump ended a meeting on infrastructure spending with Democratic leaders.Market Insiderread more
Controversial lawyer Michael Avenatti was indicted on charges of trying to extort athletic shoe giant Nike out of tens of millions of dollars by threatening to go public with...Politicsread more
Despite the president's claim that "you can't investigate and legislate simultaneously," certain must-pass pieces of legislation, including a debt ceiling hike, will...Politicsread more
Moody's said it's downgrading the outlook for Equifax from stable to negative, citing ongoing fallout from the company's 2018 data breach.Technologyread more
Amazon shareholders demanded the company to take action on a number of different issues during its annual shareholder meeting on Wednesday.Technologyread more
FDA Commissioner Scott Gottlieb says Amazon's new push into health care is just fine because anything that makes much needed products, like pharmaceuticals, more accessible to consumers and lowers costs is a positive.
"Disruptive competition is a good thing," Gottlieb said Friday in an interview with CNBC's "Squawk Box. "
"The supply chain, the intermediaries, are a cost on the system. So, seeing more competition into that marketplace will help bring down costs, maybe promote use of generics."
PillPack, which organizes and delivers packages of medications for consumers, is licensed to ship prescriptions in 49 states.
The move, which is the strongest indication yet of Amazon's intent to push further into health care, threatens to remove to one of the few distinguishing factors pharmacy chains have relied on to fend off the online retail giant — the sale of prescription drugs.
Gottlieb, who has a background in venture capital, said there will still be an important role for brick-and-mortar pharmacies and "incumbent players" in health care.
"If you're picking up your things in the pharmacy, you're also picking up other things as well," Gottlieb said. "My sense is this is going to be a slower evolution in the market towards disruptive systems. There's a reason why a lot of the incumbent players have built a lot of market share here."
Ana Gupte, senior health care services analyst at Leerink Partners, advised clients to remember that Amazon's push into the pharmaceutical space won't happen over night. However, she said the stock plunges Thursday on Amazon's news was "rational."
"It's going to take a long time," Gupte told "Squawk Box." "Maybe they get 5 percent market share after quite a while. But that threat will be there and they will grow share over time."
Gupte expects the new service will also attract Amazon's Prime members to its other products, saying it's a "pretty good cross sell move."
—CNBC's Angelica LaVito contributed to this report.